This invention generally relates to a phototherapy apparatus, and more specifically to a precisely guided phototherapy apparatus.
Phototherapy is a medical and veterinary technique which uses lasers, light emitting diodes (LEDs) or other types of light sources to stimulate or inhibit cellular function. Recently, this technique has been widely used for treating soft tissue injury, chronic pain, and promoting wound healing for both human and animal targets.
Typically, the phototherapy procedure involves radiating light energy in the ultraviolet (UV), visible, or infrared wavelength onto or into the patient's skin. It is highly desirable to precisely control the dose of light energy that is applied on a specific treatment area to achieve an optimum therapeutic effect. However, none of the existing phototherapy apparatuses could fulfill this task due to the following reasons. First, the therapeutic light generally has a non-uniform beam profile, i.e. the light intensity varies significantly from the center to the edge of the light beam. Thus the treatment area inevitably receives uneven energy dosages. Second, some therapeutic light (e.g. the infrared light) is invisible to the human eyes. In these cases, an aiming beam in the visible wavelength is generally provided to guide the therapeutic light. However, due to their wavelength and power difference, the aiming beam generally has an intensity profile different from that of the therapeutic light, which prevents it from providing precise dosage guidance to the clinician or practitioner. Third, the practitioner or clinician usually needs to scan the therapeutic light beam to cover a large treatment area, making it even harder to track the exact delivered energy dosage for any specific region of the area.
There thus exists a need for an improved phototherapy apparatus, which can provide real time monitoring of the delivered light energy dosage on the subject surface of the patient for assisting the practitioner or clinician in precisely controlling the phototherapy procedure.
It is the overall goal of the present invention to solve the above mentioned problems and provide a precisely guided phototherapy apparatus. The phototherapy apparatus comprises sensor means for monitoring the intensity, position, and movement of the therapeutic light beam over the treatment area. The delivered light energy dosage is determined accordingly based on these parameters. The phototherapy apparatus further comprises a projector device for projecting markers on top of the treatment area. The markers represent the values of the delivered light energy dosage for assisting the practitioner or clinician in precisely controlling the phototherapy procedure.
The accompanying figures, where like reference numerals refer to identical or functionally similar elements throughout the separate views and which together with the detailed description below are incorporated in and form part of the specification, serve to further illustrate various embodiments and to explain various principles and advantages all in accordance with the present invention.
Skilled artisans will appreciate that elements in the figures are illustrated for simplicity and clarity and have not necessarily been drawn to scale. For example, the dimensions of some of the elements in the figures may be exaggerated relative to other elements to help to improve understanding of embodiments of the present invention.
Before describing in detail embodiments that are in accordance with the present invention, it should be observed that the embodiments reside primarily in combinations of method steps and apparatus components related to a precisely guided phototherapy apparatus. Accordingly, the apparatus components and method steps have been represented where appropriate by conventional symbols in the drawings, showing only those specific details that are pertinent to understanding the embodiments of the present invention so as not to obscure the disclosure with details that will be readily apparent to those of ordinary skill in the art having the benefit of the description herein.
In this document, relational terms such as first and second, top and bottom, and the like may be used solely to distinguish one entity or action from another entity or action without necessarily requiring or implying any actual such relationship or order between such entities or actions. The terms “comprises,” “comprising,” or any other variation thereof, are intended to cover a non-exclusive inclusion, such that a process, method, article, or apparatus that comprises a list of elements does not include only those elements but may include other elements not expressly listed or inherent to such process, method, article, or apparatus. An element proceeded by “comprises . . . a” does not, without more constraints, preclude the existence of additional identical elements in the process, method, article, or apparatus that comprises the element.
Referring to
In this exemplary embodiment, the output wand 104 and the projector 110 share the same optical path with their output light beams combined by a beam combiner 118 (e.g. a dichroic beam combiner). Thus the projected markers 114 coincide with the laser beam 120 on the subject surface. The digital light projector 110 may further project a visible image of the intensity profile of the laser beam 120 (e.g. a contour image with different intensity levels displayed in different colors) onto the surface of the biological tissue 106. The visible image coincides with the infrared laser beam such that its intensity, position, and movement are revealed to the practitioner or clinician. The values of the intensity profile, as well as the energy dosage distribution, can be displayed on top of the visible image. A plurality of grids 116, either in the form of a transparent grid paper, or projected lines from the light projector 110, may be introduced on top of the subject surface to facilitate tracking of the therapeutic light beam. The output wand 104, the image sensor 108, and the light projector 110 of the present embodiment can be integrated together to form a common outputting/sensing/projecting port for the phototherapy apparatus. Before the phototherapy procedure, the light projector 110 may display a simulated or pre-recorded laser beam profile in accordance to the selected laser parameters (e.g. output power of the laser, distance from the output wand to the tissue), which assists the practitioner/clinician in optimizing the treatment procedure.
In a simplified variation of the present embodiment, the digital light projector 110 may be replaced with a laser or LED pointer, which projects different colored light onto the subject surface. The color varies in accordance to the delivered light energy dosage for assisting the practitioner/clinician with energy dosage control. The image sensor 108 may be replaced with a plurality of photo detectors for recording the intensity, position, and movement of the therapeutic light beam. Alternatively, the position and movement of the output wand 104 (hence the position and movement of the therapeutic light beam) can be tracked with other types of sensors, such as thermal, mechanical, electrical, magnetic, or acoustic sensors.
In another variation of the present embodiment, the phototherapy apparatus further comprises a temperature sensor, preferably in the form of a non-contact infrared temperature sensor for monitoring the temperature of the subject biological tissue. Through the light projector, the measured temperature value is projected onto the surface of the biological tissue as a means to control the light energy dosage.
In yet another variation of the present embodiment, the phototherapy apparatus may comprise multiple laser sources with different output wavelengths to treat biological tissues with different type and concentration of chromophores. The outputs of the multiple laser sources can be combined at adjustable proportions and simultaneously applied to the biological tissue to achieve an enhanced treatment result. The laser sources may operate in a pulsed mode such that a high peak power is produced to increase the penetration depth of the laser light and/or to trigger nonlinear photochemical reactions yet the average power of the laser light is maintained at low levels to avoid any tissue damage.
The disclosed phototherapy apparatus can be used in other fields as well, such as photo-dynamic therapy, where the light source is used to activate a photosensitizing drug, or in aesthetic treatments such as acne treatment, wrinkle removal, skin-tightening, etc.
In the foregoing specification, specific embodiments of the present invention have been described. However, one of ordinary skill in the art appreciates that various modifications and changes can be made without departing from the scope of the present invention as set forth in the claims below. The numerical values cited in the specific embodiment are illustrative rather than limiting. Accordingly, the specification and figures are to be regarded in an illustrative rather than a restrictive sense, and all such modifications are intended to be included within the scope of present invention. The benefits, advantages, solutions to problems, and any element(s) that may cause any benefit, advantage, or solution to occur or become more pronounced are not to be construed as a critical, required, or essential features or elements of any or all the claims. The invention is defined solely by the appended claims including any amendments made during the pendency of this application and all equivalents of those claims as issued.
This application claims an invention which was disclosed in Provisional Patent Application No. 61/309,671, filed Mar. 2, 2010, entitled “PRECISELY GUIDED PHOTOTHERAPY APPARATUS”. The benefit under 35 USC §119(e) of the above mentioned United States Provisional Applications is hereby claimed, and the aforementioned application is hereby incorporated herein by reference.
Number | Name | Date | Kind |
---|---|---|---|
4718416 | Nanaumi | Jan 1988 | A |
4928695 | Goldman et al. | May 1990 | A |
5409481 | Poppas et al. | Apr 1995 | A |
5820553 | Hughes | Oct 1998 | A |
5860967 | Zavislan et al. | Jan 1999 | A |
5928221 | Sasnett et al. | Jul 1999 | A |
5959725 | Ghosh | Sep 1999 | A |
6123719 | Masychev | Sep 2000 | A |
6267779 | Gerdes | Jul 2001 | B1 |
6312451 | Streeter | Nov 2001 | B1 |
6413267 | Dumoulin-White et al. | Jul 2002 | B1 |
6436127 | Anderson et al. | Aug 2002 | B1 |
6556858 | Zeman | Apr 2003 | B1 |
6641578 | Mukai | Nov 2003 | B2 |
6690964 | Bieger et al. | Feb 2004 | B2 |
6790205 | Yamazaki et al. | Sep 2004 | B1 |
6887233 | Angeley et al. | May 2005 | B2 |
6935748 | Kaufman et al. | Aug 2005 | B2 |
6984228 | Anderson et al. | Jan 2006 | B2 |
6984288 | Dhindsa et al. | Jan 2006 | B2 |
7001413 | Butler | Feb 2006 | B2 |
7217266 | Anderson et al. | May 2007 | B2 |
7282060 | DeBenedictis et al. | Oct 2007 | B2 |
7309335 | Altshuler et al. | Dec 2007 | B2 |
7544163 | MacKinnon et al. | Jun 2009 | B2 |
7720306 | Gardiner et al. | May 2010 | B2 |
7824395 | Chan et al. | Nov 2010 | B2 |
7831017 | Myles | Nov 2010 | B2 |
7918796 | Nycz et al. | Apr 2011 | B2 |
7988688 | Webb et al. | Aug 2011 | B2 |
7993289 | Quistgaard et al. | Aug 2011 | B2 |
8033284 | Porter et al. | Oct 2011 | B2 |
8092447 | Dolleris | Jan 2012 | B2 |
8235530 | Maad | Aug 2012 | B2 |
8308642 | Zhou et al. | Nov 2012 | B2 |
20020002330 | Vilsmeier | Jan 2002 | A1 |
20020023652 | Riaziat et al. | Feb 2002 | A1 |
20020065461 | Cosman | May 2002 | A1 |
20020133144 | Chan et al. | Sep 2002 | A1 |
20040002641 | Sjogren et al. | Jan 2004 | A1 |
20040158300 | Gardiner | Aug 2004 | A1 |
20050143793 | Korman et al. | Jun 2005 | A1 |
20050195587 | Moctezuma De La Barrera et al. | Sep 2005 | A1 |
20050265516 | Haider | Dec 2005 | A1 |
20060030908 | Powell et al. | Feb 2006 | A1 |
20060079757 | Smith et al. | Apr 2006 | A1 |
20060116669 | Dolleris | Jun 2006 | A1 |
20070253614 | Jung et al. | Nov 2007 | A1 |
20080015553 | Zacharias | Jan 2008 | A1 |
20080033410 | Rastegar et al. | Feb 2008 | A1 |
20080033412 | Whelan et al. | Feb 2008 | A1 |
20080051773 | Ivanov et al. | Feb 2008 | A1 |
20080065056 | Powell et al. | Mar 2008 | A1 |
20080091249 | Wang | Apr 2008 | A1 |
20080240353 | Myles | Oct 2008 | A1 |
20090029310 | Pumphrey et al. | Jan 2009 | A1 |
20090153837 | Wang et al. | Jun 2009 | A1 |
20110183304 | Wallace et al. | Jul 2011 | A1 |
20120045742 | Meglan et al. | Feb 2012 | A1 |
20120095533 | Wang | Apr 2012 | A1 |
20120194814 | Wang | Aug 2012 | A1 |
Number | Date | Country |
---|---|---|
WO 0178830 | Oct 2001 | WO |
Entry |
---|
Roundy C.B., Current Technology of Laser Beam Profile Measurements, Spiricon Inc. , 1995. |
Wheeland R.G., Clinical Uses of Lasers in Dermatology, Lasers in Surgery and Medicine 162-23 (1995). |
Tanghetti E. & Gillis P., Photometric and clinical assessment of localized UVB phototherapy systems for the high-dosage treatment of stable plaque psoriasis, J Cosmetic & Laser Ther 2003; 5: 101-106. |
Number | Date | Country | |
---|---|---|---|
20110218597 A1 | Sep 2011 | US |
Number | Date | Country | |
---|---|---|---|
61309671 | Mar 2010 | US |